Perrigo EBITDA Margin 2010-2025 | PRGO

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Perrigo (PRGO) over the last 10 years. The current EBITDA margin for Perrigo as of March 31, 2025 is .
Perrigo EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $4.34B $0.55B 12.68%
2024-12-31 $4.37B $0.45B 10.24%
2024-09-30 $4.39B $0.32B 7.22%
2024-06-30 $4.43B $0.31B 6.95%
2024-03-31 $4.56B $0.40B 8.85%
2023-12-31 $4.66B $0.51B 11.04%
2023-09-30 $4.65B $0.57B 12.31%
2023-06-30 $4.63B $0.54B 11.71%
2023-03-31 $4.56B $0.46B 10.18%
2022-12-31 $4.45B $0.42B 9.37%
2022-09-30 $4.40B $0.41B 9.22%
2022-06-30 $4.35B $0.79B 18.25%
2022-03-31 $4.20B $0.67B 15.89%
2021-12-31 $4.14B $0.72B 17.35%
2021-09-30 $4.09B $0.74B 18.01%
2021-06-30 $4.05B $0.40B 9.91%
2021-03-31 $4.02B $0.61B 15.19%
2020-12-31 $4.09B $0.65B 15.85%
2020-09-30 $3.39B $0.58B 16.99%
2020-06-30 $3.58B $0.56B 15.57%
2020-03-31 $3.78B $0.55B 14.53%
2019-12-31 $3.87B $0.57B 14.65%
2019-09-30 $4.71B $0.71B 15.01%
2019-06-30 $4.65B $0.53B 11.46%
2019-03-31 $4.69B $0.59B 12.48%
2018-12-31 $4.73B $0.65B 13.78%
2018-09-30 $4.82B $0.71B 14.80%
2018-06-30 $4.92B $1.00B 20.32%
2018-03-31 $4.97B $1.05B 21.19%
2017-12-31 $4.95B $1.02B 20.64%
2017-09-30 $4.99B $0.39B 7.79%
2017-06-30 $5.03B $-1.24B -24.70%
2017-03-31 $5.13B $-1.21B -23.54%
2016-12-31 $5.28B $-1.57B -29.69%
2016-09-30 $2.93B $-1.68B -57.33%
2016-06-30 $2.94B $-0.04B -1.50%
2015-12-31 $1.22B $0.04B 3.53%
2015-09-30 $3.31B $1.72B 51.87%
2014-12-31 $3.03B $1.68B 55.38%
2014-09-30 $2.94B $1.52B 51.79%
2013-12-31 $2.83B $1.51B 53.43%
2013-09-30 $2.74B $1.39B 50.84%
2012-12-31 $2.43B $1.33B 54.50%
2012-09-30 $2.39B $1.28B 53.48%
2011-12-31 $2.26B $1.17B 51.97%
2011-09-30 $2.14B $1.05B 48.95%
2010-12-31 $1.90B $1.00B 52.56%
2010-09-30 $1.76B $0.85B 48.44%
2009-12-31 $1.62B $0.81B 50.06%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.730B $4.373B
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.137B 27.79
Boston Scientific (BSX) United States $154.602B 38.70
Stryker (SYK) United States $145.939B 30.51
EssilorLuxottica (ESLOY) France $128.884B 0.00
Medtronic (MDT) Ireland $105.694B 14.98
Haleon (HLN) United Kingdom $51.038B 29.05
Lonza Group Ag (LZAGY) Switzerland $49.182B 0.00
ResMed (RMD) United States $35.941B 27.00
GE HealthCare Technologies (GEHC) United States $32.753B 15.55
Agilent Technologies (A) United States $32.296B 20.98
Terumo (TRUMY) Japan $27.790B 36.10
Insulet (PODD) United States $22.791B 89.46
Koninklijke Philips (PHG) Netherlands $21.581B 15.51
Zimmer Biomet Holdings (ZBH) United States $18.467B 11.86
Baxter (BAX) United States $15.754B 11.76
Smith & Nephew SNATS (SNN) United Kingdom $12.622B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.194B 21.55
Lantheus Holdings (LNTH) United States $5.225B 13.18
Prestige Consumer Healthcare (PBH) United States $4.175B 18.65
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.309B 24.40
Haemonetics (HAE) United States $3.259B 14.85
Envista Holdings (NVST) United States $3.129B 26.00
GN Store Nord (GNNDY) Denmark $2.215B 18.35
QuidelOrtho (QDEL) United States $2.080B 14.30
LeMaitre Vascular (LMAT) United States $1.832B 40.94
AtriCure (ATRC) United States $1.687B 0.00
Neogen (NEOG) United States $1.348B 17.25
Acuren (TIC) United States $1.300B 0.00
AdaptHealth (AHCO) United States $1.212B 12.30
Kestra Medical Technologies (KMTS) United States $1.165B 0.00
Green Thumb Industries (GTBIF) United States $1.111B 25.00
BioLife Solutions (BLFS) United States $1.060B 0.00
Phibro Animal Health (PAHC) United States $1.000B 12.78
InMode (INMD) Israel $0.922B 9.29
CeriBell (CBLL) United States $0.615B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.604B 0.00
Evolus (EOLS) United States $0.602B 0.00
Curaleaf Holdings (CURLF) Canada $0.582B 0.00
Valneva SE (VALN) France $0.535B 0.00
Owens & Minor (OMI) United States $0.502B 4.17
Tilray Brands (TLRY) Canada $0.468B 0.00
Capricor Therapeutics (CAPR) United States $0.461B 0.00
Surmodics (SRDX) United States $0.422B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.342B 0.00
Cresco Labs (CRLBF) United States $0.333B 0.00
VAREX IMAGING (VREX) United States $0.325B 11.94
Canopy Growth (CGC) Canada $0.314B 0.00
Aurora Cannabis (ACB) Canada $0.310B 55.20
Sanara MedTech (SMTI) United States $0.261B 0.00
Viemed Healthcare (VMD) United States $0.260B 21.90
ZimVie (ZIMV) United States $0.250B 11.35
Sanuwave Health (SNWV) United States $0.241B 0.00
Verano Holdings (VRNOF) United States $0.237B 0.00
Cerus (CERS) United States $0.235B 0.00
OraSure Technologies (OSUR) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.207B 0.00
Quanterix (QTRX) United States $0.203B 0.00
Brainsway (BWAY) Israel $0.197B 52.15
Biote (BTMD) United States $0.197B 5.53
Omeros (OMER) United States $0.195B 0.00
Organigram Global (OGI) Canada $0.185B 0.00
High Tide (HITI) Canada $0.177B 0.00
Utah Medical Products (UTMD) United States $0.177B 14.44
Exagen (XGN) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.142B 17.46
Jin Medical (ZJYL) China $0.119B 0.00
TerrAscend (TSNDF) Canada $0.110B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Fonar (FONR) United States $0.089B 11.52
MacroGenics (MGNX) United States $0.088B 0.00
Agape ATP (ATPC) $0.088B 0.00
Quipt Home Medical (QIPT) United States $0.077B 0.00
Veru (VERU) United States $0.075B 0.00
InterCure (INCR) Israel $0.072B 0.00
Zynex (ZYXI) United States $0.072B 0.00
Apyx Medical (APYX) United States $0.060B 0.00
Jushi Holdings (JUSHF) United States $0.058B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
United Health Products (UEEC) United States $0.054B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
Modular Medical (MODD) United States $0.048B 0.00
United-Guardian (UG) United States $0.038B 13.19
Rockwell Medical (RMTI) United States $0.032B 0.00
Nephros (NEPH) United States $0.028B 37.57
Safety Shot (SHOT) United States $0.021B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00